XML 19 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Jan. 01, 2017
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities:      
Net income (loss)   $ (34,539)  
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Depreciation and amortization   100,709  
Impairment expense    
Inventory write-down    
Deferred income taxes    
Provision for doubtful accounts   3,648  
(Gain) loss on disposal of assets   (10,517)  
Share-based compensation expense   22,109  
Amortization of deferred financing costs   430  
Accretion of original issue discount    
Reorganization items, net    
Changes in operating assets and liabilities:      
Accounts receivable   (207,907)  
Inventory   (20,441)  
Prepaid and other current assets   11,222  
Accounts payable   45,018  
Payroll and related costs and accrued expenses   24,629  
Liabilities subject to compromise    
Other   4,805  
Net cash used in operating activities   (60,834)  
Cash flows from investing activities:      
Purchases of and deposits on property, plant and equipment   (151,445)  
Proceeds from disposal of property, plant and equipment and non-core service lines   36,741  
Other payments related to non-core service lines    
Net cash used in investing activities   (114,704)  
Cash flows from financing activities:      
Proceeds from revolving debt    
Payments on revolving debt and term loan    
Proceeds from DIP Facility    
Payments on DIP Facility    
Payments of capital lease obligations    
Financing costs   (1,739)  
Proceeds from issuance of common stock, net of offering costs   215,920  
Employee tax withholding on restricted stock vesting   (3,842)  
Excess tax expense from share-based compensation    
Net cash provided by financing activities   210,339  
Effect of exchange rate changes on cash   (2,919)  
Net increase in cash and cash equivalents   31,882  
Cash and cash equivalents, beginning of period $ 181,242 181,242  
Cash and cash equivalents, end of period   213,124  
Predecessor [Member]      
Cash flows from operating activities:      
Net income (loss) 298,582   $ (825,921)
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Depreciation and amortization   164,557
Impairment expense   430,406
Inventory write-down   13,399
Deferred income taxes (4,613)   (126,522)
Provision for doubtful accounts   1,021
(Gain) loss on disposal of assets   4,220
Share-based compensation expense   15,523
Amortization of deferred financing costs   49,318
Accretion of original issue discount   52,913
Reorganization items, net (315,626)   37,582
Changes in operating assets and liabilities:      
Accounts receivable   125,911
Inventory   7,624
Prepaid and other current assets   19,640
Accounts payable   (91,481)
Payroll and related costs and accrued expenses (1,436)   43,780
Liabilities subject to compromise (33,000)  
Other   (4,714)
Net cash used in operating activities (56,093)   (82,744)
Cash flows from investing activities:      
Purchases of and deposits on property, plant and equipment   (44,606)
Proceeds from disposal of property, plant and equipment and non-core service lines   30,775
Other payments related to non-core service lines   (1,827)
Net cash used in investing activities   (15,658)
Cash flows from financing activities:      
Proceeds from revolving debt   174,000
Payments on revolving debt and term loan   (13,250)
Proceeds from DIP Facility   24,500
Payments on DIP Facility (25,000)  
Payments of capital lease obligations   (2,171)
Financing costs (2,248)   (1,009)
Proceeds from issuance of common stock, net of offering costs 200,000  
Employee tax withholding on restricted stock vesting   (409)
Excess tax expense from share-based compensation   (5,592)
Net cash provided by financing activities 172,752   176,069
Effect of exchange rate changes on cash   (2,156)
Net increase in cash and cash equivalents 116,659   75,511
Cash and cash equivalents, beginning of period 64,583 $ 64,583 25,900
Cash and cash equivalents, end of period $ 181,242   $ 101,411